J&J's latest Texas two-step strategy on brink of victory / J&J Talc Settlement Holdouts Accuse Company of Buying Votes / J&J CFO Wolk on Product Pipeline, Strategy, Talc Lawsuit / J&J discontinues dengue drug study after changes in R&D portfolio / J&J Offers $8 Billion to Win Over Cancer Victims and Texas Judges / J&J Takes Aim at Hospital Drug-Discount Program / J&J Allies With Mass-Tort Specialists to Seal $8 Billion Talc Settlement / Study links talc use to ovarian cancer -- a potential boon for thousands suing J&J / Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival / J&J Can't Promise Wall Street No More Tears